BioCentury
ARTICLE | Company News

Covis, GlaxoSmithKline sales and marketing update

February 17, 2014 8:00 AM UTC

Covis launched 0.0625 and 0.1875 mg strengths of Lanoxin digoxin in the U.S. to treat mild to moderate heart failure and chronic atrial fibrillation. For both doses, a 100-tablet package has a wholes...